 sensit cross-react beta-lactam antibiot high-risk patient cystic fibrosi immunogen allergen cross-react aztreonam patient cystic fibrosi CF year well-docu histori allerg system reaction sr and/or cephalosporin antipseudomon beta-lactam antibiot bla skin test st penicilloyl-polylysin ppl minor determin mixtur antipseudomon bla posit patient bla recent allerg reaction minor determin mixtur ppl posit st-posit patient serum ppl-specif ige antibodi detect ppl-specif igg antibodi patient st reagent neg patient patient ST posit polylysin conjug aztreonam SQ prior exposur patient aztreonam exposur SR initi treatment cours reexposur patient asymptomat intraven desensit posit aztreonam reagent skin respons repeat aztreonyl-specif ige igg serum antibodi patient patient allerg reaction thu aztreonam high-risk patient CF allerg bla immunogen serolog test caution aztreonam bla-allerg patient CF light ST cross-react sensit rate studi